Yoo Jin Lee

6PUBLICATIONS
22CO-AUTHORS
Haematological tumoursPredictive and prognostic markersHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
Adverse Events Associated with Advanced Therapy Compared with Conventional Therapy in Patients with Inflammatory Bowel Disease: A Common Data Model Analysis.

|May 30, 2024
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type.

Soyeon Choi, Jae-Cheol Jo, Yoo Jin Lee

|Apr 28, 2024
Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy.

Yoo Jin Lee, Hyun-Ki Kim, Youjin Kim

|Apr 20, 2023
Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.

Sang Hyuk Park, Hyun-Ki Kim, Joseph Jeong

|Apr 19, 2020
Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL).

Jae-Cheol Jo, Jin Seok Kim, Je-Hwan Lee

|Jul 31, 2019
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma.

Yoo Jin Lee, Joon Ho Moon, Sang Kyun Sohn

Pageof 1

Frequent Collaborators

4 joint publications

Jae-Cheol Jo

1 joint publications

Ji Hyun Lee

1 joint publications

Jin Seok Kim

1 joint publications

Je-Hwan Lee